Skip to content

For providers

Gain actionable clinical insights with our whole genome platform

Order a test

Whole genome coverage

Standard panel testing looks at less than 0.1% of your genome1.  Our whole genome sequencing platforms provide an extensive analysis of your patient’s genomic makeup, including complex mutations (structural variants, copy number variants, variants in non-coding areas) that are not covered by other panel and exome sequencing tests.

Targeted panel sequencing

< 0.1 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations

Whole exome sequencing

1 – 2 %

Genome-wide coverage

  • Limited number of point mutations
  • Limited copy number variations
  • Limited structural variations
  • Non-coding areas not covered

Whole genome sequencing

> 99 %

Genome-wide coverage

  • More point mutations identified
  • More accurate, genome-wide copy number variations
  • Genome-wide coverage of structural variations
  • Non-coding areas also covered

At Inocras, our goal is to help relieve your diagnostic burden so you can spend more time on what matters most: caring for your patients. Our whole genome platform provides you with additional data, tools, and confidence to support your best medical decision making.

Actionable findings

Our proprietary high-performing bioinformatics algorithm thoroughly analyzes a patient’s genome data and translates it into actionable findings. Our user-friendly report is comprehensive and highlights the findings highly relevant to clinical utility.

Clinical trial matching

We provide detailed clinical trial information matched with each patient’s biomarkers and other pre-screening criteria, saving you time in finding the best matched clinical trials for patients.

*For cancer only

Expert support

You’ll have access to our in-house genomic experts (on demand) while our dedicated sales and medical teams are just a phone call away. Your patient will also have access to a genetic counselor session. This counselor is also available to address any questions you may have.

Available tests

We offer WGS-based diagnostic solutions for cancer and rare diseases.


See your patient’s cancer from new angles. Our whole genome cancer test provides a broader insight compared to many conventional genetic tests.

Learn more

Rare disease

Find clarity in the face of complexity. We combine bioinformatics with in-house clinical expertise to provide timely, accurate, and clinically meaningful insights.

Learn more

How to order a test

Ordering a test is quick and easy at our provider order portal


Start an online order by filling out the test requisition form. We will send our kits to your office.


Use our supplied sample collection kit and instructions to collect samples for testing.


Ship the samples directly to us.


Receive the test results via email and fax. You can also access all test results you ordered in our online portal.

Test requirements



10 FFPE from curls or slides, with an H&E stained slide for reference

Paired normal

10mL peripheral blood, or
previously extracted DNA from a CLIA certified laboratory

Turnaround time

2 weeks from receipt of patient samples at our lab



Peripheral blood (3-5 mL)

Turnaround time

2 weeks from receipt of patient samples at our lab

What other providers are saying


“I was finally able to understand why my patient with ER+ breast cancer had an atypical response to the endocrine treatment through Inocras’s whole genome sequencing results. It identified not only somatic mutation (RB1), but also germline mutation (gBRCA2) and mutational signatures (WGS-HRD), which were not captured in other tests. Based on the results, I could predict the current treatment (CDK inhibitor) would have poor outcomes and change the treatment plan completely. It was eye-opening to see both somatic and germline mutations as well as all types of mutational signatures. My patient’s treatment journey would have been much easier if she had undergone a whole genome test at the beginning of her treatment journey.”

Dr. Park, Medical Oncologist - Samsung Medical Center

*This testimonial is based on collaborative research funded by Inocras.

Frequently asked questions

If you don’t see your question answered here, please contact us at

How do I order a test?

To order a test, please sign up and complete the online test requisition form. Our sales representatives will follow up with you shortly.

How are the tests paid for?

Our tests are not currently covered by insurance. Upon ordering, your patient will receive an invoice for which payment will be required directly from the patient’s out-of-pocket expenses.

How will I receive the results?

You can access Inocras test reports as soon as they are ready via our digital provider order portal. You can also receive access to results via secure email or request to have results faxed to you.

What if I have questions about my patient’s results?

You’ll have access to our team of in-house medical experts, researchers, and genomic scientists who can explain the results to you and answer any questions. If you have questions about a patient’s results, you can email us at for support. One of our experts will respond to your questions or set up time to speak with you.